Crescent Biopharma CBIO Cash Flow Statement (2013-2026)

NASDAQ CBIO
$14.76 +0.23 (+1.58%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Crescent Biopharma Quarterly Cash Flow Statement

Periods 54 quarters
Latest Jun 2026

Crescent Biopharma reported cash from operations of -$19.46M and free cash flow of -$19.48M for the quarter ended Jun 2026, down 18.7% year over year. This cash flow statement covers 54 quarters of results from Mar 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-17.33M-17.42M-14.65M-13.27M-8.52M-10.24M-10.36M-8.26M-9.20M-9.08M-10.74M-10.10M-9.82M-7.20M-2.34M-21.79M-24.61M-90.40M-23.28M-24.84M
Depreciation and DepletionDep. & Depletion
0.07M0.06M0.06M0.05M0.05M0.05M0.04M0.04M0.04M0.02M0.01M0.01M0.01M0.00M0.03M0.05M0.06M0.07M
Share-based CompensationStock Comp.
1.59M1.32M1.08M0.96M0.91M0.90M0.87M0.86M0.89M0.91M1.19M1.21M1.14M1.13M1.23M5.34M1.99M4.75M4.11M3.96M
Gains from Sales and DivestituresGains Divest
0.03M
Asset Writedowns and ImpairmentWritedown
0.03M
Cash from OperationsCash from Ops.
-16.95M-12.81M-13.70M-16.23M-8.62M-7.91M-11.61M-6.97M-8.68M-7.61M-10.51M-8.89M-8.00M-6.27M-10.85M-16.40M-17.55M-26.73M-8.94M-19.46M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.07M0.06M0.06M0.05M0.05M0.05M0.04M0.04M0.04M0.02M0.01M0.01M0.01M0.00M0.03M0.05M0.06M0.07M
Change in Working Capital
Change in ReceivablesChange Receivables
-18.00M
Change in Account PayablesChange Payables
0.22M0.72M0.17M-1.01M-0.42M0.12M-0.49M-0.24M0.09M0.54M-0.11M0.20M-0.37M-0.25M-0.22M-0.21M1.49M1.02M-2.31M1.50M
Change in Accured ExpensesChange Accured Exp.
-0.70M0.88M0.76M-2.87M-0.80M1.18M-1.38M-0.10M-0.20M-0.09M-1.32M-0.95M0.52M2.17M1.76M2.66M2.00M-1.06M-3.46M2.97M
Other Working Capital ChangesOther WC Changes
1.41M-1.87M0.41M0.07M1.20M0.62M-0.27M-0.26M-0.26M-0.20M-0.18M-0.35M-0.22M0.04M0.37M0.76M-0.28M4.17M-1.04M2.99M
Investing Activities
Capital ExpendituresCapex
0.00M0.00M0.04M0.04M0.00M1.000.00M0.01M0.01M801.000.01M0.00M0.14M0.59M0.19M0.15M0.01M
Change in IntangiblesChange Intangibless
8.00M
Cash from Investing ActivitiesCash from Investing
-0.00M-0.00M-0.04M-0.04M-0.00M-1.00-0.00M-0.01M-0.01M-801.00-0.01M-0.00M-0.14M-0.59M-72.19M-8.15M1.76M
Financing Activities
Other financing activitiesOther financing
0.00M0.17M
Cash from Financing ActivitiesCash from Financing
0.02M1.14M28.74M0.02M0.06M999.000.00M500.0041.03M-1.49M146.86M-1.25M178.86M-6.95M0.14M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
1.14M28.71M0.00M500.004.00M0.01M178.88M0.28M
Additional items
Change in Cash
-16.93M-11.67M-13.74M-16.27M-8.62M-3.75M17.13M-6.97M-8.63M-7.61M-10.51M-8.90M-7.99M34.77M-12.34M130.32M-19.38M79.93M-24.03M-17.57M
Free Cash FlowFCF
-16.95M-12.81M-13.74M-16.27M-8.62M-7.91M-11.61M-6.99M-8.69M-7.62M-10.52M-8.90M-8.00M-6.27M-10.85M-16.54M-18.13M-26.93M-9.08M-19.48M
Net Cash FlowNCF
-16.93M-11.67M-13.74M-16.27M-8.62M-7.91M17.13M-6.97M-8.63M-7.61M-10.51M-8.90M-8.00M34.77M-12.34M130.32M-19.39M79.94M-24.03M-17.57M

Crescent Biopharma Cash Flow Statement API

Pull Crescent Biopharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CBIO&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY